IBDEI1DH ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22880,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22880,1,3,0)
 ;;=3^Personal Hx Malig Neop Trachea
 ;;^UTILITY(U,$J,358.3,22880,1,4,0)
 ;;=4^Z85.12
 ;;^UTILITY(U,$J,358.3,22880,2)
 ;;=^5063409
 ;;^UTILITY(U,$J,358.3,22881,0)
 ;;=Z85.42^^104^1066^23
 ;;^UTILITY(U,$J,358.3,22881,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22881,1,3,0)
 ;;=3^Personal Hx Malig Neop Parts of Uterus
 ;;^UTILITY(U,$J,358.3,22881,1,4,0)
 ;;=4^Z85.42
 ;;^UTILITY(U,$J,358.3,22881,2)
 ;;=^5063419
 ;;^UTILITY(U,$J,358.3,22882,0)
 ;;=Z79.01^^104^1067^16
 ;;^UTILITY(U,$J,358.3,22882,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22882,1,3,0)
 ;;=3^L/T (Current) Use of Anticoagulants
 ;;^UTILITY(U,$J,358.3,22882,1,4,0)
 ;;=4^Z79.01
 ;;^UTILITY(U,$J,358.3,22882,2)
 ;;=^5063330
 ;;^UTILITY(U,$J,358.3,22883,0)
 ;;=Z76.0^^104^1067^18
 ;;^UTILITY(U,$J,358.3,22883,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22883,1,3,0)
 ;;=3^Medication Renewal
 ;;^UTILITY(U,$J,358.3,22883,1,4,0)
 ;;=4^Z76.0
 ;;^UTILITY(U,$J,358.3,22883,2)
 ;;=^5063297
 ;;^UTILITY(U,$J,358.3,22884,0)
 ;;=R79.1^^104^1067^2
 ;;^UTILITY(U,$J,358.3,22884,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22884,1,3,0)
 ;;=3^Abnormal Coagulation Profile
 ;;^UTILITY(U,$J,358.3,22884,1,4,0)
 ;;=4^R79.1
 ;;^UTILITY(U,$J,358.3,22884,2)
 ;;=^5019591
 ;;^UTILITY(U,$J,358.3,22885,0)
 ;;=Z95.810^^104^1067^1
 ;;^UTILITY(U,$J,358.3,22885,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22885,1,3,0)
 ;;=3^AICD
 ;;^UTILITY(U,$J,358.3,22885,1,4,0)
 ;;=4^Z95.810
 ;;^UTILITY(U,$J,358.3,22885,2)
 ;;=^5063674
 ;;^UTILITY(U,$J,358.3,22886,0)
 ;;=I25.3^^104^1067^3
 ;;^UTILITY(U,$J,358.3,22886,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22886,1,3,0)
 ;;=3^Aneurysm of Heart
 ;;^UTILITY(U,$J,358.3,22886,1,4,0)
 ;;=4^I25.3
 ;;^UTILITY(U,$J,358.3,22886,2)
 ;;=^5007112
 ;;^UTILITY(U,$J,358.3,22887,0)
 ;;=I35.9^^104^1067^4
 ;;^UTILITY(U,$J,358.3,22887,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22887,1,3,0)
 ;;=3^Aortic Valve Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,22887,1,4,0)
 ;;=4^I35.9
 ;;^UTILITY(U,$J,358.3,22887,2)
 ;;=^5007178
 ;;^UTILITY(U,$J,358.3,22888,0)
 ;;=Z95.2^^104^1067^26
 ;;^UTILITY(U,$J,358.3,22888,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22888,1,3,0)
 ;;=3^Presence of Prosthetic Heart Valve
 ;;^UTILITY(U,$J,358.3,22888,1,4,0)
 ;;=4^Z95.2
 ;;^UTILITY(U,$J,358.3,22888,2)
 ;;=^5063670
 ;;^UTILITY(U,$J,358.3,22889,0)
 ;;=I74.9^^104^1067^5
 ;;^UTILITY(U,$J,358.3,22889,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22889,1,3,0)
 ;;=3^Arterial Embolism/Thrombosis,Unspec
 ;;^UTILITY(U,$J,358.3,22889,1,4,0)
 ;;=4^I74.9
 ;;^UTILITY(U,$J,358.3,22889,2)
 ;;=^5007805
 ;;^UTILITY(U,$J,358.3,22890,0)
 ;;=I48.91^^104^1067^6
 ;;^UTILITY(U,$J,358.3,22890,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22890,1,3,0)
 ;;=3^Atrial Fibrillation,Unspec
 ;;^UTILITY(U,$J,358.3,22890,1,4,0)
 ;;=4^I48.91
 ;;^UTILITY(U,$J,358.3,22890,2)
 ;;=^5007229
 ;;^UTILITY(U,$J,358.3,22891,0)
 ;;=I48.92^^104^1067^7
 ;;^UTILITY(U,$J,358.3,22891,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22891,1,3,0)
 ;;=3^Atrial Flutter,Unspec
 ;;^UTILITY(U,$J,358.3,22891,1,4,0)
 ;;=4^I48.92
 ;;^UTILITY(U,$J,358.3,22891,2)
 ;;=^5007230
 ;;^UTILITY(U,$J,358.3,22892,0)
 ;;=Z95.0^^104^1067^8
 ;;^UTILITY(U,$J,358.3,22892,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22892,1,3,0)
 ;;=3^Cardiac Pacemaker
 ;;^UTILITY(U,$J,358.3,22892,1,4,0)
 ;;=4^Z95.0
 ;;^UTILITY(U,$J,358.3,22892,2)
 ;;=^5063668
 ;;^UTILITY(U,$J,358.3,22893,0)
 ;;=I42.8^^104^1067^9
 ;;^UTILITY(U,$J,358.3,22893,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22893,1,3,0)
 ;;=3^Cardiomyopathies NEC
